782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update

Adnan Khattak; Paolo A Ascierto; Paola Queirolo; Michael Chisamore; Daniela Kleine-Kohlbrecher; Nadia Viborg; Mads Lausen; Stine F Thorsen; Thomas Trolle; Anders Jespersen; Georgina V Long

doi:10.1136/jitc-2023-SITC2023.0782-H

Citation Tools

Regular Abstracts – Part 2

Clinical Trial In Progress

782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Khattak A, Ascierto PA, Queirolo P, et al

782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update

Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0782-H

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password